Shared by
beno
Fundamentals
N/a
Catalysts / News / Painting the picture
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
-May 01 2020: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Modernas Vaccine (mRNA-1273)
-May 06 2020: Weak earnings / lags estimates, FDA approves phase 2 of COVID-19 vaccine
Technical Analysis
-SPY pattern: Runner
-Intraday pattern: Runner
-Levels: 52, 54.5, 55.5, 57.3, 59, 60
Strategy / Confluence / Sizing Guide / Risk
Strategy: First test long of 57.3 level
Confluence: N/a
Strike Zone: 57.44 - 57
Sizing (lots): 2
Risk (stop / Rs): 56.99
Review / Lessons Learned
OGT, followed sizing and slowly scaled out starting at my first target.
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2020-05-08 12:35:05 | MRNA | buy | $57.450 | long |
| 2020-05-08 12:35:13 | MRNA | buy | $57.350 | long |
| 2020-05-08 12:36:31 | MRNA | sell | $57.680 | long |
| 2020-05-08 12:38:06 | MRNA | sell | $57.830 | long |
| 2020-05-08 12:38:25 | MRNA | sell | $57.800 | long |
| 2020-05-08 12:39:10 | MRNA | sell | $57.840 | long |
| 2020-05-08 12:39:14 | MRNA | sell | $57.840 | long |
| 2020-05-08 12:40:23 | MRNA | sell | $57.650 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!